For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
VAYLFLFCAIFVEVVATTLLKSTEGFTRLVPTLACLAGYAVTFTLLALSISRGMKTDVAYALWSAIGTAA IVLIAVLFLDSPVSVAKVVGVALIIVGVITLNLADAH
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. leprae Br4923 | MLBr_01756 | - | - | 100% (107) | putative multidrug resistance protein |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb3092 | mmr | 3e-43 | 79.05% (105) | multidrugs-transport integral membrane protein MMR |
| M. gilvum PYR-GCK | Mflv_3553 | - | 9e-13 | 36.11% (108) | small multidrug resistance protein |
| M. tuberculosis H37Rv | Rv3065 | mmr | 3e-43 | 79.05% (105) | multidrugs-transport integral membrane protein MMR |
| M. abscessus ATCC 19977 | MAB_2640c | - | 3e-11 | 29.81% (104) | putative multidrug resistance protein |
| M. marinum M | MMAR_1612 | mmr | 4e-35 | 68.22% (107) | multidrug-transport integral membrane protein Mmr |
| M. avium 104 | MAV_3949 | - | 4e-42 | 77.57% (107) | transporter, small multidrug resistance (SMR) family protein |
| M. smegmatis MC2 155 | MSMEG_3672 | - | 1e-16 | 39.42% (104) | transporter, small multidrug resistance (SMR) family protein |
| M. thermoresistible (build 8) | TH_2224 | - | 2e-16 | 40.00% (95) | transporter, small multidrug resistance (SMR) family protein |
| M. ulcerans Agy99 | MUL_3425 | mmr | 2e-34 | 67.29% (107) | multidrug-transport integral membrane protein Mmr |
| M. vanbaalenii PYR-1 | Mvan_0339 | - | 2e-30 | 60.75% (107) | small multidrug resistance protein |
CLUSTAL 2.0.9 multiple sequence alignment
Mb3092|M.bovis_AF2122/97 -------MIYLYLLCAIFAEVVATSLLKSTEGFTRLWPTVGCLVGYGIAF
Rv3065|M.tuberculosis_H37Rv -------MIYLYLLCAIFAEVVATSLLKSTEGFTRLWPTVGCLVGYGIAF
MLBr_01756|M.leprae_Br4923 -------MAYLFLFCAIFVEVVATTLLKSTEGFTRLVPTLACLAGYAVTF
MAV_3949|M.avium_104 MRARGGVLTYLFLICAILAEVVATSLLKSTQGFTRLWPTVICLLGYAVSF
MMAR_1612|M.marinum_M -------MAYLLLLGAIAMEVMATSFLKSTEGFTRLWPTVICLTVYGFSF
MUL_3425|M.ulcerans_Agy99 -------MAYLLLLGAIAMEVMATSFLKSTEGFTRLWPTVICLTIYGFSF
Mvan_0339|M.vanbaalenii_PYR-1 ----MPGVAWTLLGGAILAEVIATSMLKSTEGFTRLWPTLACLLLYGAAF
MAB_2640c|M.abscessus_ATCC_199 -------MVWLVLVLAGLLEVGWAIGLKYTEGFTRLWPTVGTVGSMIISI
MSMEG_3672|M.smegmatis_MC2_155 -------MMWLALAGAILVEVVATLSLRASDGFRRRAWIVPVVIGYAASF
TH_2224|M.thermoresistible__bu --------MWWVLAGAILMEVAATLSLRASEGFRRKIWIVPVVAGYTASF
Mflv_3553|M.gilvum_PYR-GCK ------MIEYVLLIAAIGCEVSATLALRVAARG-RTSFYGIVLIGYVAAF
: * * ** : *: : * : ::
Mb3092|M.bovis_AF2122/97 ALLALSISHGMQTDVAYALWSAIGTAAIVLVAVLFLGSPISVMKVVGVGL
Rv3065|M.tuberculosis_H37Rv ALLALSISHGMQTDVAYALWSAIGTAAIVLVAVLFLGSPISVMKVVGVGL
MLBr_01756|M.leprae_Br4923 TLLALSISRGMKTDVAYALWSAIGTAAIVLIAVLFLDSPVSVAKVVGVAL
MAV_3949|M.avium_104 ALLAVSISRGMQTDVAYALWSAIGTALIVLIAVLFLGSPISVTKVVGVGL
MMAR_1612|M.marinum_M AMLAMSIARGMQTDVAYALWSAIGTGAIVLIAVLFLGSHLSLTKVLGVGL
MUL_3425|M.ulcerans_Agy99 AMLAMSTARGMQTDVAYALWSAIGTGAIVLIVVLFLGSHLSLTKVLGVGL
Mvan_0339|M.vanbaalenii_PYR-1 MLLAQSISHGMQVGIAYALWSAIGTTVIVAVGVTFLGEPISTLKVIGVAL
MAB_2640c|M.abscessus_ATCC_199 ALLGIAMKS-LPVGTAYAIWVGVGAVGTAILGIVLFGDSANVWRLLSLGL
MSMEG_3672|M.smegmatis_MC2_155 YLLWVALSLGVPVGVAYGIWTACGVALVAVVARILFRDPLTPMMMLGIAL
TH_2224|M.thermoresistible__bu ALLWWTLALGMPVGVAYGIWTACGVALIALIARWLFAEPLTRTTLLGIAL
Mflv_3553|M.gilvum_PYR-GCK TLLWASLRHGMPLGVAYGIWAAAGVALTAAFSRLLFDEPLTRKMLGGIAL
:* : : . **.:* . *. . . :: . . : .:.*
Mb3092|M.bovis_AF2122/97 IVVGVVTLNLAGAH-
Rv3065|M.tuberculosis_H37Rv IVVGVVTLNLAGAH-
MLBr_01756|M.leprae_Br4923 IIVGVITLNLADAH-
MAV_3949|M.avium_104 IIAGVVTLNLTGAH-
MMAR_1612|M.marinum_M IIGGVLTLNLTGAH-
MUL_3425|M.ulcerans_Agy99 IIGGVLTLNLTGAH-
Mvan_0339|M.vanbaalenii_PYR-1 VVSGVVTLQLDGHQA
MAB_2640c|M.abscessus_ATCC_199 IVAGIIGLKLAT---
MSMEG_3672|M.smegmatis_MC2_155 IASGVFTIELAGVTH
TH_2224|M.thermoresistible__bu IVAGVLTIEVFGGVH
Mflv_3553|M.gilvum_PYR-GCK IMVGVLLVEIG-ASH
: *:. :::